دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Contents
doi : 10.1016/S0161-6420(23)00094-5
Volume 130, Issue 5, May 2023, Pages A5, A6, A8, A10, A11
This Issue at a Glance
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2023.03.007
Volume 130, Issue 5, May 2023, Page 449
A Simple Vista en Este Número
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2023.03.008
Volume 130, Issue 5, May 2023, Pages e1-e2
å…Â�责声明: 美国眼科å¦会对翻译ä¸Â出现的任何éâ€�™è¯¯ã€Â�
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2023.03.013
Volume 130, Issue 5, May 2023, Page e3
Disentangling the Impact of Reticular Pseudodrusen Phenotype and the ARMS2/HTRA1 Risk Allele in Geographic Atrophy: The AREDS 2 Study Report 32
Bonnie B. Huang, BS Amani A. Fawzi, MD
doi : 10.1016/j.ophtha.2023.02.010
Volume 130, Issue 5, May 2023, Pages 460-461
Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Aidan B. Jackson, BSci, MClinRes,1,2 Keith R. Martin, DM, FRCOphth, 1,2,3 Michael A. Coote, MBBS, FRANZCO, 1,2 Felipe A. Medeiros, MD, PhD,4 Christopher A. Girkin, MD, MSPH,5 Massimo A. Fazio, PhD,5 Jeffrey M. Liebmann, MD,6 Carlos Gustavo De Moraes, MD, PhD,6 Robert N. Weinreb, MD, 7 Linda M. Zangwill, PhD, 7 Zhichao Wu, BAppSc(Optom), PhD
doi : 10.1016/j.ophtha.2023.01.008
Volume 130, Issue 5, May 2023, Pages 462-468
Validation of Rates of Mean Deviation Change as Clinically Relevant End Points for Glaucoma Progression
Felipe A. Medeiros, MD, PhD,1,2,3 Alessandro A. Jammal, MD, PhD 1
doi : 10.1016/j.ophtha.2022.12.025
Volume 130, Issue 5, May 2023, Pages 469-477
Incidence of Retinal Detachment, Macular Edema, and Ocular Hypertension after Neodymium:Yttrium-Aluminum-Garnet Capsulotomy: A Population-Based Nationwide Study—The French YAG 2 Study
Corinne Dot, MD, PhD,1 Cédric Schweitzer, MD, PhD,2 Antoine Labbé, MD, PhD,3 François Lignereux, MD,4 Pascal Rozot, MD,5 Mélanie Goguillot, DipEng, 6 Françoise Bugnard, MSc,6 Antoine P. Brézin, MD, PhD 7
doi : 10.1016/j.ophtha.2022.12.022
Volume 130, Issue 5, May 2023, Pages 478-487
Severe Chorioretinal Folds after Optical Neuritis
V�TOR M IRANDA , MD MARIA J. M ATIAS , MD RAQUEL S OARES , MD
doi : 10.1016/j.ophtha.2022.07.014
Volume 130, Issue 5, May 2023, Page 487
Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32
Elvira Agrón, MA,1 Amitha Domalpally, MD, PhD,2 Catherine A. Cukras, MD, PhD,1 Traci E. Clemons, PhD,3 Qingyu Chen, PhD,4 Anand Swaroop, PhD,5 Zhiyong Lu, PhD,4 Emily Y. Chew, MD, 1 Tiarnan D.L. Keenan, BM BCh, PhD,1 for the AREDS and AREDS2 Research Groups
doi : 10.1016/j.ophtha.2022.11.026
Volume 130, Issue 5, May 2023, Pages 488-500
Preretinal Microvascular Tufts Associated with Dyskeratosis Congenita
NATHALIE GHOMASHCHI , MD 1 JEAN -F RANÇOIS KOROBELNIK , MD 1,2 MARIE -N OËLLE D ELYFER , MD, PH D
doi : 10.1016/j.ophtha.2022.07.026
Volume 130, Issue 5, May 2023, Page 500
Navigating Coronavirus Disease 2019 Vaccination and Uveitis: Identifying the Rates and Risk of Recurrent Uveitis after Coronavirus Disease Vaccination
Charlotte A. Jordan, MBChB, PhD,1 Stephanie Townend, MBChB,2 Natalie Allen, MBChB,1 Joanne Sims, MBChB, FRANZCO,2 Charles N.J. McGhee, PhD, FRCOphth, 1,2 Rachael L. Niederer, PhD, FRANZCO
doi : 10.1016/j.ophtha.2022.12.013
Volume 130, Issue 5, May 2023, Pages 501-508
Associations between Serial Intravitreal Injections and Dry Eye
Agni Malmin, MD,1,2 Vilde M. Thomseth, MD,1,3 Per T. Førland, MD,1 Ayyad Z. Khan, MD, PhD,4 Hanne B. Hetland, MSc,5 Xiangjun Chen, MD, PhD,4,6,7 Inga-Britt K. Haugen, PhD,8 Tor P. Utheim, MD, PhD,1,2,4,6,7 Vegard A. Forsaa, MD, PhD
doi : 10.1016/j.ophtha.2023.01.009
Volume 130, Issue 5, May 2023, Pages 509-515
Anterior Segment and Macular OCT in Alport Syndrome
CHIARA ZAFFALON , MD 1,2 FRANCESCO R OMANO , MD 2 ANNA PAOLA SALVETTI , MD
doi : 10.1016/j.ophtha.2022.07.005
Volume 130, Issue 5, May 2023, Page 515
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study
Joseph Tauber, MD,1 Gregg J. Berdy, MD,2 David L. Wirta, MD,3 Sonja Krösser, PhD,4 Jason L. Vittitow, PhD,5 on behalf of the GOBI Study Group
doi : 10.1016/j.ophtha.2022.12.021
Volume 130, Issue 5, May 2023, Pages 516-524
Systemic Treatment Reduces Von-Hippel-Lindau–Associated Retinal Capillary Hemangioblastoma
AARON M. FAIRBANKS, MD SANDRA H OYEK , MD NIMESH A. P ATEL , MD
doi : 10.1016/j.ophtha.2022.07.007
Volume 130, Issue 5, May 2023, Page 524
Augmented-Dose Unilateral Recession-Resection Procedure in Acute Acquired Comitant Esotropia
Yulian Zhou, MD,1,2,3 Ling Ling, MBBS,1,2,3 Xiying Wang, MD,1,2,3 Chao Jiang, MD,1,2,3 Wen Wen, MD, PhD,1,2,3 Chen Zhao, MD, PhD
doi : 10.1016/j.ophtha.2022.12.019
Volume 130, Issue 5, May 2023, Pages 525-532
Gardasil-9 Vaccine as a Possible Treatment Option for Human Papillomavirus Conjunctival Papilloma
ISHITH SETH , BB IOMED (H ONS ), MD PHILIPP R OBERTS , MD, P H D DANIELLE CADIEUX , MD, BS C
doi : 10.1016/j.ophtha.2022.07.022
Volume 130, Issue 5, May 2023, Page 532
Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment
Carl W. Baker, MD,1 Kristin Josic, PhD, 2 Maureen G. Maguire, PhD,2 Lee M. Jampol, MD,3 Daniel F. Martin, MD,4 Soraya Rofagha, MD, MPH,5 Jennifer K. Sun, MD, MPH,6 for the DRCR Retina Network
doi : 10.1016/j.ophtha.2022.12.008
Volume 130, Issue 5, May 2023, Pages 533-541
The Efficacy of Defocus Incorporated Multiple Segments Lenses in Slowing Myopia Progression: Results from Diverse Clinical Circumstances
Jiaxin Liu, MD,1 Yiqiu Lu, MD,1, * Dan Huang,2 Jiwen Yang, MD, PhD,3 Chunlei Fan, MD,4 Chunmei Chen, MD,5 Jianhua Li, MD,6 Qinqin Wang,7 Shan Li, MD,8 Baolin Jiang, MD,9 Hongyan Jiang, MD,10 Xiaoning Li, MD, PhD,1,11,12,13 Zhikuan Yang, MD, PhD,1,11,12,13 Weizhong Lan, MD, PhD
doi : 10.1016/j.ophtha.2023.01.007
Volume 130, Issue 5, May 2023, Pages 542-550
A Rare Case of Nonexpulsive Total Iridodialysis
V�TOR M IRANDA , MD ISABEL LOPES -C ARDOSO , MD
doi : 10.1016/j.ophtha.2022.07.018
Volume 130, Issue 5, May 2023, Page 550
Association between Aphakia and Endophthalmitis after Pediatric Cataract Surgery
SARAH HILKERT RODRIGUEZ , MD, MPH 1 LINDSAY Y. CHUN , MD 1 DIMITRA SKONDRA , MD, P HD 1 CHUANHONG L IAO , MS 2
doi : 10.1016/j.ophtha.2022.11.029
Volume 130, Issue 5, May 2023, Pages 551-553
Clinical Outcomes after Ocular Trauma with Orbeez Gel Pellet Projectiles
BENJAMIN R. LIN , MD 1 HASENIN A L-K HERSAN , MD 1 TYLER R OWSEY , MD 2 MATTHEW W EST , MD 2 ALBERT LIN , MD 3 PHILLIP QU , MD 3 ELENA BITRIAN , MD 1 JULIA HUDSON , MD 1 MICHAEL V ENINCASA , MD 1 JASON FAN , MD, P H D1 NAOMI G UTKIND , MD 1 J. D ANIEL DIAZ , MD 4 PRASHANT PAREKH , MD 5 HARRIS SULTAN , MD 6 NICOLAS A. Y ANNUZZI , MD
doi : 10.1016/j.ophtha.2023.01.013
Volume 130, Issue 5, May 2023, Pages 553-555
Re: Freedman et al: Low- and very low-dose bevacizumab for retinopathy of prematurity: reactivations, additional treatments, and 12-month outcomes (Ophthalmology. 2022;129:1120–1128)
V �CTOR M ANUEL A SENSIO -S �NCHEZ , MD
doi : 10.1016/j.ophtha.2022.12.016
Volume 130, Issue 5, May 2023, Page e18
Reply
SHARON F. F REEDMAN , MD 1 D AVID K. W ALLACE , MD, MPH
doi : 10.1016/j.ophtha.2022.12.017
Volume 130, Issue 5, May 2023, Pages e18-e19
